Article · 26 Feb 2026
Review articlePublished 15 Jul 2016
Manufacturing of viral vectors for gene therapy: part I. Upstream processing
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Manufacturing technologies for the production of clinical grade viral vectors have been significantly improved in recent years. This is of utmost importance for gene therapy approaches used in the treatment of inherited or acquired diseases. This article briefly describes the general principles for the production of viral vectors. The specific sections are dedicated to more detailed descriptions of the production of adenoviral, AAV, γ-retroviral and lentiviral vectors. A subsequent article (the second part) will then deal with downstream processing (purification) of viral vectors.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Bioprocessing.
Article · 29 Nov 2025
Adaptive Bioprocess Control: Enabling Intelligent and Robust Biomanufacturing
Article · 29 Nov 2025
Advanced Foam Control Strategies in Bioprocessing
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Bioprocessing
- SubjectPharmaceutical Sciences
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Otto-Wilhelm Merten”
- BylineArticles whose byline prints “Matthias Schweizer”
- BylineArticles whose byline prints “Parminder Chahal”
- BylineArticles whose byline prints “Amine A Kamen”